May 12, 2017 / 12:44 PM / 3 months ago

BRIEF-Opexa Therapeutics quarterly loss per share $0.12

May 12 (Reuters) - Opexa Therapeutics Inc:

* Quarterly loss per share $0.12

* Opexa Therapeutics Inc - cash and cash equivalents were $2.8 million as of March 31, 2017, compared to $3.4 million as of December 31, 2016

* Opexa Therapeutics Inc - in addition to assessing strategic options, co is conducting a review of its research and development programs other than Tcelna Source text:(bit.ly/2pFac1G) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below